Archives
Mechanisms and Classifications of Chronic Obstructive Pulmonary Disease: A literature review
Maria Murphy
Faculty of Health Sciences, ACU National; Department of Nursing and Ambulatory Care Services, Austin Health, Fitzroy VIC
John E Saunders
Deputy Dean, Faculty of Health Sciences, Australian Catholic University, Fitzroy VIC
Michelle Campbell
School of Nursing, Australian Catholic University, Fitzroy VIC
Abstract
COPD is a prevalent chronic health condition secondary to only heart disease and stroke. A review of the literature reveals whilst smoking is the most common aetiological factor, environmental and occupational pollutions, genetic predisposition, hyper-responsive airways and respiratory infections are additional mechanisms to the development of COPD in susceptible individuals.
Assessment of the severity of COPD via spirometry is considered the gold standard in quantifying the degree of respiratory impairment experienced by the client with the condition. However, there are inconsistent parameters of disease severity between each of the international respiratory bodies, which must influence reporting of outcomes.
This paper reviews the literature reports of the mechanisms; systemic effects, disease-staging systems used in COPD and the relationship between disease severity and health outcomes.
Keywords
lung diseases, COPD, classifications, mechanisms, nursing
References
Agusti AG, Noguera A, Sauleda J, Sala E, Pons J and Busquets X (2003) Systemic effects of chronic obstructive pulmonary disease. European Respiratory Journal 21(2): 347-360.
AIHW (2002) Cardiovascular risk factors report, Australian Institute of Health and Welfare. Retrieved 15/03/2002 from www.aihw.gov.au/pls/cvd/cvd_ris.show_report.
Alvisi V, Mirkovic T, Nesme P, Guerin C and Milic-Emili J (2003) Acute effects of hyperoxia on dyspnea in hypoxemia patients with chronic airway obstruction at rest. Chest 123(4): 1038-1046.
American Thoracic Society (ATS) (1995a) Standardization of Spirometry 1994 Update. American Journal of Respiratory and Critical Care Medicine 152(3): 1107-1136.
ATS (1995b) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Journal of Respiratory Critical Care Medicine 152: s77-120.
Bach PB, Brown C, Gelfand SE and McCrory DC (2001) Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. Annals Internal Medicine 134(7): 600-620.
Barbarito N, Ceriana P and Nava S (2001) Respiratory muscles in chronic obstructive pulmonary disease and asthma. Minerva Anestesiolgy 67(9): 653-658.
Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW and Wedzicha JA (1999) Usefulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54: 581-586.
British Thoracic Society (BTS) (1997) Guidelines for the management of Chronic Obstructive Pulmonary Disease. Thorax 52(Suppl 5): S1-S28.
Casaburi R (2001) Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Medical Science in Sports Exercise 33(7 Suppl): S662-670.
Casanova C, Cote C, de Torres JP, Aguirre-Jaime A, Marin JM, Pinto-Plata V and Celli BR (2005) Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 171(6): 591-597.
Celli BR, Halbert RJ, Isonaka S and Schau B (2003) Population impact of different definitions of airway obstruction. European Respiratory Journal 22: 268-273.
Chen JC and Mannino DM (1999) Worldwide epidemiology of chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine 5(2): 93.
Chitkara RK and Sarinas PS (2002) Recent advances in diagnosis and management of chronic bronchitis and emphysema. Current Opinion in Pulmonary Medicine 8(2): 126-136.
Clinical Evaluation and Health Service Evaluation Unit (1999) Hospital management of an acute exacerbation of chronic obstructive pulmonary disease, evidenced based guidelines. Melbourne: Western Hospital.
Cooper CB (1995) Determining the role of exercise in patients with chronic pulmonary disease. Medical Science in Sports Exercise 27(2): 147-157.
Crapo RO (1994) Current concepts: pulmonary function testing. The New England Journal of Medicine 331(1): 25-30.
Crockett AJ, Cranston JM and Moss JR (2002) Economic Case Statement, Chronic Obstructive Pulmonary Disease. Adelaide: Flinders Medical Centre.
Croxton TL, Weinmann GG, Senior RM, Wise RA, Crapo JD and Buist AS (2003) Clinical research in chronic obstructive pulmonary disease: needs and opportunities. American Journal of Respiratory and Critical Care Medicine 167(8): 1142-1149.
Decramer M (2001) Respiratory muscles in COPD: regulation of trophical status. Verhandelingen Konin Academie voor Geneeskurnd Belgie 63(6): 577-602; discussion 602-574.
Diaz OVC, Villafranca C,Ghezzo H, Borzone G, Leiva A, Milic-Emili J and Lisboa C (2001) Breathing Pattern and gas exchange at peak exercise in COPD patients with and without tidal flow limitation at rest. European Respiratory Journal 17(6): 1120-1127.
Eid AA, Ionescu AA, Nixon LS, Lewis-Jenkins V, Matthews SB, Griffiths TL, Shale DJ. (2001) Inflammatory response and body composition in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 164(8 Pt 1): 1414-1418.
Farquhar SL and Fantasia L (2005) Pulmonary anatomy and physiology and the effects of COPD. Home Health Nurse 23(3): 167-174; quiz 175-166.
Ferreira IM, Brooks D, Lacasse Y, Goldstein RS and White J (2002) Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Systematic Review 1: CD000998.
Ferrer M, Alonso J, Morera J, Marrades RM, Khalaf A, Aguar MC Plaza V, Prieto L and Anto JM (1997) Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Annals Internal Medicine 127(12): 1072-1079.
Fujimoto K, Matsuzawa Y, Yamaguchi S, Koizumi T and Kubo K (2002) Benefits of oxygen on exercise performance and pulmonary hemodynamics in patients with COPD with mild hypoxemia. Chest 122(2): 457-463.
Gerald LB and Bailey WC (2002) Global Initiative for Chronic Obstructive Lung Disease. Journal of Cardiopulmonary Rehabilitation 22(4): 234-244.
Glady CA, Aaron SD, Lunau M, Clinch J and Dales RE (2003) A spirometry-based algorithm to direct lung function testing in the pulmonary function laboratory. Chest 123(6) 1939-1946.
Gronkiewicz C and Borkgren-Okonek M (2004) Acute exacerbations of COPD: nursing application of evidenced based guidelines. Critical Care Nursing Quarterly 27(4): 336-352.
Haccoun C, Smountas AA, Gibbons WJ, Bourbeau J and Lands LC (2002) Isokinetic Muscle Function in COPD. Chest 121, 1079-1084.
Hajiro T, Nishimura K, Tsukino M, Ikeda A and Oga T (2000) Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease. Respiratory Medicine 94(9): 841-846.
Halbert RJ, Isonaka S, George D and Iqbal A (2003) Interpreting COPD prevalence estimates: what is the true burden of disease? Chest 123(5): 1684-1692.
Haluszka J, Chartrand DA, Grassino AE and Milic-Emili J (1990) Intrinsic PEEP and arterial PCO2 in stable patients with chronic obstructive pulmonary disease. American Review Respiratory Disease 141(5 Pt 1): 1194-1197.
Harik-Khan RI, Fleg JL and Wise RA (2002) Body Mass Index and the risk of COPD. Chest 121, 370-376.
Hay JG, Stone P, Carter J, Church S, Eyre-Brook A, Pearson MG, Woodcock AA, and Calverley PM (1992) Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. European Respiratory Journal 5(6): 659-664.
Hess DR, MacIntyre NR, Mishoe SC, Galvin WF, Adams AB and Saposnick AB (2002) Respiratory Care: Principles and Practice. Philadelphia, WB Saunders Company.
Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers R M, Sciurba FC, Coxson HO and Pare PD (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. New England Journal of Medicine 350(26): 2645-2653.
Hughes JMB and Pride NB (2000) Lung Function Tests: Physiological Principles and Clinical applications. London, WB Saunders.
Huiart L, Ernst P and Suissa S (2005) Cardiovascular morbidity and mortality in COPD. Chest 128(4): 2640-2646.
Iqbal A, Schloss S, George D and Isonaka S (2002) Worldwide guidelines for chronic obstructive pulmonary disease: a comparison of diagnosis and treatment recommendations. Respirology 7(3): 233-239.
Jenkins C (2003) Sharpening the clinical diagnostic borders of chronic obstructive pulmonary disease. Internal Medicine Journal 33: 551-553.
Lacasse Y, Maltais F and Goldstein RS (2002) Smoking cessation in pulmonary rehabilitation: goal or prerequisite? Journal of Cardiopulmonary Rehabilitation 22(3): 148-153.
Larson JL, Covey MK and Corbridge S (2002) Inspiratory muscle strength in chronic obstructive pulmonary disease. AACN Clinical Issues 13(2): 320-332.
Levine S, Kaiser L, Leferovich J and Tikunov B (1997) Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. New England Journal of Medicine 337(25): 1799-1806.
Lowe A, Campbell D, Walker P, Farish S, Jackson B and Dharmage S (2003) Clustering effects of chronic obstructive pulmonary disease specific quality of life in hospitalized patients. Respirology 8(3): 339-343.
Mannino DM (2002) COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 121(5 Suppl): 121S-126S.
McKenzie DK, Frith PA, Burdon JGW and Town GI (2003) The COPDX Plan: Australian & New Zealand Guidelines for the Management of Chronic Obstructive Pulmonary Disease 2003. Medical Journal of Australia 178(March 17): s1-s39.
Mergoni M and Rossi A (2001) [Physiopathology of acute respiratory failure in COPD and asthma]. Minerva Anestesiolgy 67(4) 198-205.
Murray CJL and Lopez AD (2002) The Global Burden of Disease. Retrieved 11 April 2002 from www.who.ont/msa/mnh/ems/dalys.
National Colloborating Centre for Chronic Conditions (2004) Chronic Obstructive Pulmonary Disease, National clinical guideline on management of Chronic Obstructive Pulmonary Disease in adults in primary and secondary care. Thorax 59(Supp1): 1-232.
National Heart Lung and Blood Institute (NHLBI) / World Health Organization (WHO) (2001) Global strategy for the diagnostic, management and prevention of chronic obstructive pulmonary disease Workshop report (No. NIH publication no 2701) Bethesda: National Institutes of Health, National Heart, Lung and Blood Institute.
O'Donnell DE (2001) Ventilatory limitations in chronic obstructive pulmonary disease. Medicine Science in Sports Exercise 33(7 Suppl): S647-655.
Pauwels RA, Buist AS, Ma P, Jenkins CR and Hurd SS (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respiratory Care 46(8): 798-825.
Pettersen CA and Adler KB (2002) Airways inflammation & COPD. Chest 121: 142s-150s.
Piitulainen E, Areberg J, Linden M, Eriksson S, Mattsson S and Wollmer P (2002) Nutritional status & muscle strength in patients with emphysema & severe alpha1-antitrypsin deficiency. Chest 122: 1240-1246.
Polkey MI (2002) Muscle metabolism and exercise tolerance in COPD. Chest 121(5): 131-135.
Prescott E, Almdal T, Mikkelsen KL, Tofteng CL, Vestbo J and Lange P (2002) Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. European Respiratory Journal 20(3): 539-544.
Regional COPD working group (2003) COPD prevalence in 12 Asia-Pacific countries and regions: Projections based on the COPD prevalence estimation model. Respirology 8 192-198.
Reid DW, Soltani A, Johns DP, Bish R, Williams T, Burns GP and Walters EH (2003) Bronchodilator reversibility in Australian adults with chronic obstructive pulmonary disease. Internal Medicine Journal 33(12): 572-577.
Schroeder EB, Welch VL, Couper D, Nieto FJ, Liao D, Rosamond WD and Heiss G (2003) Lung function and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. American Journal of Epidemiology 158(12): 1171-1181.
Selim AJ, Ren XS, Fincke G, Rogers W, Lee A and Kazis L (1997) A symptom-based measure of the severity of chronic lung disease: results from the Veterans Health Study. Chest 111(6): 1607-1614.
Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J and Howard P (1995) Optimal assessment and management of chronic obstructive pulmonary disease (COPD) The European Respiratory Society Task Force. European Respiratory Journal 8(8): 1398-1420.
Sietsema K (2001) Cardiovascular limitations in chronic pulmonary disease. Medicine Science in Sports Exercise 33(7 Suppl): S656-661.
Sin DD and Man SF (2003) Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 107(11): 1514-1519.
Sutherland ER and Cherniack RM (2004) Management of chronic obstructive pulmonary disease. New England Journal of Medicine 350(26): 2689-2697.
Tan WC (2002) The global initiative for chronic obstructive lung disease: GOLD standards and the Asia - Pacific perspective. Respirology 7: 1-2.
Troosters T, Casaburi R, Gosselink R and Decramer M (2005) Pulmonary rehabilitation in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 172(1) 19-38.
Thoracic Society of Australia & New Zealand (TSANZ) (2005) Respiratory Function Tests and their application. Position Statement. Melbourne: Thoracic Society of Australia & New Zealand.
Tsoumakidou M, Tsanakis N, Voulgaraki O, Mitrouska I, Chrysofakis G and Samiou M (2004) Is there any correlation between the ATS, BTS, ERS and GOLD COPD's severity scales and the frequency of hospital admissions? Respiratory Medicine 98: 178-183.
WHO (2006) COPD: Burden. Retrieved 10 January 2006 from www.who.int./respiratory/copd/burden/en/print.html.
Williams SJ and Bury MR (1989) Impairment, disability and handicap in chronic respiratory illness. Social Science Medicine 29(5): 609-616.
Wouters EFM, Creutzberg EC and Schols AMWJ (2002) Systemic effects in COPD. Chest 121(127s-130s).
eContent Home